prohealth longevity bpc-157 BPC-157, 500 mcg, 60 Capsules : Target ProHealth Longevity BPC‑157 Claims Evaluated:
Description
Drug interactions: Potential interactions with medications that affect blood clotting, blood pressure, or growth factors remain understudied
2.4.1 Other potential methods for overcoming anti CD38 mAbs resistance: the role of CD47 CD47, an integrin-associated receptor, is widely expressed on the surface of many cell types, including red blood cells and cancer cells (60)
However, one 2017 study found BPC-157 actually reduced tumor growth by 45% in colon cancer models (Tkalcevic et al., 2017)
You et al
